Press Releases - WDM Group PR Network
Global Diabetes Devices and Drugs Market is Expected to Reach USD 98.4 Billion in 2018: Transparency Market Research
AACU, AUA Establish New UROPAC Affiliation Agreement
Labguru Integrates Multiplexing Protocols
General Inquiries:
BioData Ltd.
Michal Frenkiel
VP, Marketing
+972-52-620-1111
michal.frenkiel@biodata.com
Media Contacts:
Alan Zachary, Ph.D.
+ (1) 312-506-5220
azachary@harrisdmckinney.com
Ryan Ferrell
+ (1) 312-506-5202
rferrell@harrisdmckinney.com
APEX Announces Extension of Issuer Bid
Director
(403) 270-7873
(403) 270-7814 (FAX)
TiGenix's New European Production Facility Obtains EMA Approval for Commercial Production of ChondroCelect
For more information:
Eduardo Bravo
Chief Executive Officer
eduardo.bravo@tigenix.com
Claudia D'Augusta
Chief Financial Officer
claudia.daugusta@tigenix.com
Hans Herklots
Director Investor & Media Relations
hans.herklots@tigenix.com
+32 16 39 60 97
Genetic Technologies Announces BREVAGen(TM) Attains Clearance for Sale Into Florida
FOR FURTHER INFORMATION PLEASE CONTACT
Dr. Paul D.R. MacLeman
Chief Executive Officer
Genetic Technologies Limited
Phone: +61 3 8412 7000
Rudi Michelson (Australia)
Monsoon Communications
+61 3 9620 3333
Laura Landry (USA)
BluePrint Life Science Group
+1 (415) 375.3340 Ext. 103


